Literature DB >> 8432461

Molecular biology and gastric carcinoma.

P A Wright1, G T Williams.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8432461      PMCID： PMC1373957          DOI： 10.1136/gut.34.2.145

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  35 in total

1.  The search for the universal fixative or 'magic juice'.

Authors:  C T Doyle; J J O'Leary
Journal:  J Pathol       Date:  1992-04       Impact factor: 7.996

2.  Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma.

Authors:  W Yasui; J Hata; H Yokozaki; H Nakatani; A Ochiai; H Ito; E Tahara
Journal:  Int J Cancer       Date:  1988-02-15       Impact factor: 7.396

3.  Ha-ras oncogene product in human gastric carcinoma: correlation with invasiveness, metastasis or prognosis.

Authors:  E Tahara; W Yasui; K Taniyama; A Ochiai; T Yamamoto; S Nakajo; M Yamamoto
Journal:  Jpn J Cancer Res       Date:  1986-06

4.  Biopsy appearances easily mistaken for malignancy in gastrointestinal endoscopy.

Authors:  P Isaacson
Journal:  Histopathology       Date:  1982-07       Impact factor: 5.087

5.  ras oncogene p21 as a tumor marker in the cytodiagnosis of gastric and colonic carcinomas.

Authors:  B Czerniak; F Herz; L G Koss; J Schlom
Journal:  Cancer       Date:  1987-11-15       Impact factor: 6.860

6.  Frequent overexpression, but not activation by point mutation, of ras genes in primary human gastric cancers.

Authors:  K Fujita; N Ohuchi; T Yao; M Okumura; Y Fukushima; Y Kanakura; Y Kitamura; J Fujita
Journal:  Gastroenterology       Date:  1987-12       Impact factor: 22.682

7.  Preparation of anti-ras Mr 21,000 protein monoclonal antibodies and immunohistochemical analyses on expression of ras genes in human stomach and thyroid cancers.

Authors:  K Yoshida; K Hamatani; H Koide; H Ikeda; N Nakamura; M Akiyama; H Tsuchiyama; E Nakayama; H Shiku
Journal:  Cancer Res       Date:  1988-10-01       Impact factor: 12.701

8.  Analysis of ras gene expression in stomach cancer by anti-ras p21 monoclonal antibodies.

Authors:  K Yoshida; K Hamatani; H Koide; Y Abe; H Ikeda; H Tsuchiyama; E Nakayama; H Shiku
Journal:  Cancer Detect Prev       Date:  1988

9.  Human HST1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT2 gene in human cancer.

Authors:  M C Yoshida; M Wada; H Satoh; T Yoshida; H Sakamoto; K Miyagawa; J Yokota; T Koda; M Kakinuma; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

10.  Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.

Authors:  N Ohuchi; P H Hand; G Merlo; J Fujita; R Mariani-Costantini; A Thor; M Nose; R Callahan; J Schlom
Journal:  Cancer Res       Date:  1987-03-01       Impact factor: 12.701
View more
  20 in total

1.  Multiple genetic alterations and behavior of cellular biology in gastric cancer and other gastric mucosal lesions:H.pylori infection, histological types and staging.

Authors:  Heng-Jun Gao; Lian-Zhen Yu; Jian-Feng Bai; Yan-Shen Peng; Gu Sun; Han-Lin Zhao; Kun Miu; Xiu-Zhen L ; Xiao-Yong Zhang; Zhi-Quan Zhao
Journal:  World J Gastroenterol       Date:  2000-12       Impact factor: 5.742

Review 2.  Preoperative staging of gastric cancer as precondition for multimodal treatment.

Authors:  A Sendler; H J Dittler; H Feussner; H Nekarda; E Bollschweiler; U Fink; H Helmberger; H Höfler; J R Siewert
Journal:  World J Surg       Date:  1995 Jul-Aug       Impact factor: 3.352

3.  Helicobacter pylori and Epstein-Barr virus infection and the p53 tumour suppressor pathway in gastric stump cancer compared with carcinoma in the non-operated stomach.

Authors:  I O Baas; B P van Rees; A Musler; M E Craanen; G N Tytgat; F M van den Berg; G J Offerhaus
Journal:  J Clin Pathol       Date:  1998-09       Impact factor: 3.411

Review 4.  Tumor suppressor genes in molecular medicine.

Authors:  F Hoppe-Seyler; K Butz
Journal:  Clin Investig       Date:  1994-08

5.  Prediction of liver metastases after gastric cancer resection with the use of learning vector quantization neural networks.

Authors:  Tomaz Jagric; Stojan Potrc; Timotej Jagric
Journal:  Dig Dis Sci       Date:  2010-02-26       Impact factor: 3.199

6.  Telomerase activity in gastric cancer and its clinical implications.

Authors:  Wen-Hua Zhan; Jin-Ping Ma; Jun-Sheng Peng; Jing-Song Gao; Shi-Rong Cai; Jian-Ping Wang; Zhang-Qing Zheng; Lei Wang
Journal:  World J Gastroenterol       Date:  1999-08       Impact factor: 5.742

Review 7.  Helicobacter pylori infection and molecular changes in gastric carcinogenesis.

Authors:  Matthias P A Ebert; Laszlo Schandl; Peter Malfertheiner
Journal:  J Gastroenterol       Date:  2002       Impact factor: 7.527

8.  Evaluation of comparative and combined antimutagenic potential of vitamin C and vitamin E using histidine mutant Salmonella typhimurium strains.

Authors:  T A Ajith; Marry Ann; Joe Thomas
Journal:  Indian J Clin Biochem       Date:  2008-03-06

9.  Coordinate increase of telomerase activity and c-Myc expression in Helicobacter pylori-associated gastric diseases.

Authors:  Guo-Xin Zhang; Yan-Hong Gu; Zhi-Quan Zhao; Shun-Fu Xu; Hong-Ji Zhang; Hong-Di Wang; Bo Hao
Journal:  World J Gastroenterol       Date:  2004-06-15       Impact factor: 5.742

10.  Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer.

Authors:  Hiraku Itadani; Hiroko Oshima; Masanobu Oshima; Hidehito Kotani
Journal:  BMC Genomics       Date:  2009-12-17       Impact factor: 3.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.